(Total Views: 278)
Posted On: 10/08/2018 3:47:48 PM
Post# of 72436
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
What a Brilliant move by Leo and Menon back in 2015 when they decided not to run a $30,000,000 P3 ABSSSI trial and instead set out to prove the anti inflammatory properties of Brilacidin for 2 different lucrative indications, OM and UP at much lower trial costs.
The success of those 2 trials now has IPIX on the verge of a MONSTER deal.
Brilliant simply Brilliant!!!!
The success of those 2 trials now has IPIX on the verge of a MONSTER deal.
Brilliant simply Brilliant!!!!
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)